On August 1, 2024, R1 RCM Inc. (NASDAQ: RCM), a prominent provider of technology-driven healthcare solutions, was acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) in an all-cash transaction valued at approximately US$8.9 billion.

Deutsche Bank and Royal Bank of Canada committed to providing debt financing for the transaction, underscoring their confidence in the strategic acquisition. White & Case served as the legal advisor for both banks, facilitating the financial arrangements necessary to complete the deal. This financing support was crucial in enabling TowerBrook and CD&R to acquire R1 RCM Inc. and take the company private.